Core Viewpoint - The company Infitop is facing significant financial distress, with projected negative net assets and potential delisting risks, stemming from financial irregularities and ongoing investor lawsuits [1][2][3]. Group 1: Financial Performance and Projections - Infitop expects a net profit loss of between 24 million and 31 million yuan for the fiscal year 2025, with projected revenues ranging from 42 million to 54 million yuan [3][7]. - The company anticipates that its net assets will be negative by the end of 2025, which will trigger a delisting risk warning, changing its stock designation from ST to *ST [2][7]. Group 2: Accounting Errors and Legal Issues - The negative net asset situation is linked to deeper issues, including accounting errors from 2019 to 2020, where some revenue recognition did not align with actual business activities [4][9]. - Infitop has faced legal repercussions due to these accounting errors, with a first-instance ruling in favor of investors, involving 477 investors and a total claim amount of 23.6228 million yuan [4][9]. - The company is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations, with the investigation still ongoing [5][10]. Group 3: Market Reactions and Future Outlook - The stock price of Infitop has been weak for several years, and the upcoming 2025 annual report will be closely monitored by the market for its audit results [12][13]. - The company is at a critical juncture, with its ability to recover from financial difficulties being a focal point for investors and market analysts [13].
又一A股濒临退市?英飞拓净资产预计为负,或将被“*ST”